PT115583B - Processo contínuo para a preparação de medicamentos anticolinérgicos - Google Patents
Processo contínuo para a preparação de medicamentos anticolinérgicos Download PDFInfo
- Publication number
- PT115583B PT115583B PT115583A PT11558319A PT115583B PT 115583 B PT115583 B PT 115583B PT 115583 A PT115583 A PT 115583A PT 11558319 A PT11558319 A PT 11558319A PT 115583 B PT115583 B PT 115583B
- Authority
- PT
- Portugal
- Prior art keywords
- bromide
- preparation
- continuous process
- anticholinergic drugs
- anticholinergic
- Prior art date
Links
- 229940079593 drug Drugs 0.000 title abstract 3
- 239000003814 drug Substances 0.000 title abstract 3
- 230000001078 anti-cholinergic effect Effects 0.000 title abstract 2
- 238000010924 continuous production Methods 0.000 title 1
- LERNTVKEWCAPOY-VOGVJGKGSA-N C[N+]1(C)[C@H]2C[C@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)C(O)(c1cccs1)c1cccs1 Chemical compound C[N+]1(C)[C@H]2C[C@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)C(O)(c1cccs1)c1cccs1 LERNTVKEWCAPOY-VOGVJGKGSA-N 0.000 abstract 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 abstract 1
- VPNYRYCIDCJBOM-UHFFFAOYSA-M Glycopyrronium bromide Chemical compound [Br-].C1[N+](C)(C)CCC1OC(=O)C(O)(C=1C=CC=CC=1)C1CCCC1 VPNYRYCIDCJBOM-UHFFFAOYSA-M 0.000 abstract 1
- 229940121948 Muscarinic receptor antagonist Drugs 0.000 abstract 1
- ASMXXROZKSBQIH-VITNCHFBSA-N aclidinium Chemical compound C([C@@H](C(CC1)CC2)OC(=O)C(O)(C=3SC=CC=3)C=3SC=CC=3)[N+]21CCCOC1=CC=CC=C1 ASMXXROZKSBQIH-VITNCHFBSA-N 0.000 abstract 1
- 229960005012 aclidinium bromide Drugs 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 239000000812 cholinergic antagonist Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 229960002462 glycopyrronium bromide Drugs 0.000 abstract 1
- 229960001361 ipratropium bromide Drugs 0.000 abstract 1
- KEWHKYJURDBRMN-ZEODDXGYSA-M ipratropium bromide hydrate Chemical compound O.[Br-].O([C@H]1C[C@H]2CC[C@@H](C1)[N@@+]2(C)C(C)C)C(=O)C(CO)C1=CC=CC=C1 KEWHKYJURDBRMN-ZEODDXGYSA-M 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000003586 protic polar solvent Substances 0.000 abstract 1
- 230000000241 respiratory effect Effects 0.000 abstract 1
- 229960000257 tiotropium bromide Drugs 0.000 abstract 1
- 229960004541 umeclidinium bromide Drugs 0.000 abstract 1
- PEJHHXHHNGORMP-AVADPIKZSA-M umeclidinium bromide Chemical compound [Br-].C=1C=CC=CC=1C([C@@]12CC[N@@+](CCOCC=3C=CC=CC=3)(CC1)CC2)(O)C1=CC=CC=C1 PEJHHXHHNGORMP-AVADPIKZSA-M 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- C07D451/06—Oxygen atoms
- C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Otolaryngology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
A PRESENTE INVENÇÃO REFERE-SE A UM NOVO PROCESSO PARA A PREPARAÇÃO DE AGENTES / FÁRMACOS ANTICOLINÉRGICOS, COMO BROMETO DE UMECLIDÍNIO, BROMETO DE TIOTRÓPIO, BROMETO DE GLICOPIRRÔNIO, BROMETO DE ACLIDÍNIO, BROMETO DE IPRATRÓPIO NO MODO DE FLUXO CONTÍNUO NA PRESENÇA DE UM OU MAIS SOLVENTES PRÓTICOS POLARES. OS MEDICAMENTOS ANTICOLINÉRGICOS ESTÃO EM UMA FORMA ADEQUADA PARA USO POR INALAÇÃO NO TRATAMENTO DE DOENÇAS RESPIRATÓRIAS, COMO ASMA OU DOENÇA PULMONAR OBSTRUTIVA CRÓNICA (DPOC).
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PT115583A PT115583B (pt) | 2019-06-17 | 2019-06-17 | Processo contínuo para a preparação de medicamentos anticolinérgicos |
EP20734291.6A EP3982923B1 (en) | 2019-06-17 | 2020-06-16 | Continuous process for the preparation of anticholinergic drugs |
PCT/GB2020/051448 WO2020254791A1 (en) | 2019-06-17 | 2020-06-16 | Continuous process for the preparation of anticholinergic drugs |
KR1020227000471A KR20220024433A (ko) | 2019-06-17 | 2020-06-16 | 항콜린 약물의 연속 제조방법 |
CN202080049646.2A CN114206863A (zh) | 2019-06-17 | 2020-06-16 | 制备抗胆碱药的连续方法 |
US17/617,725 US20220251078A1 (en) | 2019-06-17 | 2020-06-16 | Continuous Process for the Preparation of Anticholinergic Drugs |
JP2021574905A JP2022549545A (ja) | 2019-06-17 | 2020-06-16 | 抗コリン薬の調製のための連続プロセス |
CA3141271A CA3141271A1 (en) | 2019-06-17 | 2020-06-16 | Continuous process for the preparation of anticholinergic drugs |
AU2020296972A AU2020296972A1 (en) | 2019-06-17 | 2020-06-16 | Continuous process for the preparation of anticholinergic drugs |
IL288972A IL288972A (en) | 2019-06-17 | 2021-12-13 | A continuous process for the preparation of anticholinergic drugs |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PT115583A PT115583B (pt) | 2019-06-17 | 2019-06-17 | Processo contínuo para a preparação de medicamentos anticolinérgicos |
Publications (2)
Publication Number | Publication Date |
---|---|
PT115583A PT115583A (pt) | 2021-06-03 |
PT115583B true PT115583B (pt) | 2022-05-02 |
Family
ID=71120199
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT115583A PT115583B (pt) | 2019-06-17 | 2019-06-17 | Processo contínuo para a preparação de medicamentos anticolinérgicos |
Country Status (10)
Country | Link |
---|---|
US (1) | US20220251078A1 (pt) |
EP (1) | EP3982923B1 (pt) |
JP (1) | JP2022549545A (pt) |
KR (1) | KR20220024433A (pt) |
CN (1) | CN114206863A (pt) |
AU (1) | AU2020296972A1 (pt) |
CA (1) | CA3141271A1 (pt) |
IL (1) | IL288972A (pt) |
PT (1) | PT115583B (pt) |
WO (1) | WO2020254791A1 (pt) |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6908928B2 (en) | 2000-10-12 | 2005-06-21 | Bi Pharma Kg. | Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions |
UY28871A1 (es) | 2004-04-27 | 2005-11-30 | Glaxo Group Ltd | Antagonistas del receptor de acetilcolina muscarinico |
MX2007013691A (es) * | 2005-05-02 | 2008-01-21 | Boehringer Ingelheim Int | Nuevas formas cristalinas de bromuro de tiotropio. |
CN101166738B (zh) | 2005-05-02 | 2011-06-01 | 贝林格尔·英格海姆国际有限公司 | 噻托溴铵的新晶型 |
ES2396978T5 (es) | 2005-12-19 | 2015-12-04 | Sicor, Inc. | Forma cristalina novedosa de bromuro de tiotropio y procedimiento para la preparación de la misma |
RU2453547C2 (ru) | 2005-12-19 | 2012-06-20 | Сикор Инк. | Новые формы тиотропия бромида и способы их получения |
JP5333342B2 (ja) | 2009-06-29 | 2013-11-06 | 株式会社デンソー | 半導体装置 |
DK2607351T3 (en) * | 2011-12-22 | 2017-06-06 | Cerbios-Pharma S A | CONTINUOUS PROCEDURE FOR ALKYLICATION OF CYCLIC TERTIARY AMINES |
PT106142B (pt) | 2012-02-10 | 2014-07-18 | Hovione Farmaci Ncia S A | Processo para a preparação de brometo de tiotrópio |
WO2014027045A1 (en) | 2012-08-15 | 2014-02-20 | Glaxo Group Limited | Chemical process |
CZ27764U1 (cs) | 2014-08-22 | 2015-02-02 | Zentiva, K.S. | uMethanolový solvát umeclidinium bromidu |
EP3248970A1 (en) | 2016-05-27 | 2017-11-29 | Zentiva K.S. | Forms of umeclidinium bromide |
PT109740B (pt) * | 2016-11-14 | 2020-07-30 | Hovione Farmaciencia Sa | Processo para a preparação de brometo de umeclidínio |
-
2019
- 2019-06-17 PT PT115583A patent/PT115583B/pt active IP Right Grant
-
2020
- 2020-06-16 CN CN202080049646.2A patent/CN114206863A/zh active Pending
- 2020-06-16 WO PCT/GB2020/051448 patent/WO2020254791A1/en active Search and Examination
- 2020-06-16 US US17/617,725 patent/US20220251078A1/en active Pending
- 2020-06-16 CA CA3141271A patent/CA3141271A1/en active Pending
- 2020-06-16 AU AU2020296972A patent/AU2020296972A1/en active Pending
- 2020-06-16 JP JP2021574905A patent/JP2022549545A/ja active Pending
- 2020-06-16 EP EP20734291.6A patent/EP3982923B1/en active Active
- 2020-06-16 KR KR1020227000471A patent/KR20220024433A/ko unknown
-
2021
- 2021-12-13 IL IL288972A patent/IL288972A/en unknown
Also Published As
Publication number | Publication date |
---|---|
IL288972A (en) | 2022-02-01 |
AU2020296972A1 (en) | 2022-01-20 |
JP2022549545A (ja) | 2022-11-28 |
KR20220024433A (ko) | 2022-03-03 |
CN114206863A (zh) | 2022-03-18 |
CA3141271A1 (en) | 2020-12-24 |
WO2020254791A1 (en) | 2020-12-24 |
EP3982923A1 (en) | 2022-04-20 |
PT115583A (pt) | 2021-06-03 |
US20220251078A1 (en) | 2022-08-11 |
EP3982923B1 (en) | 2024-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DOP2018000020A (es) | Tricíclicos sustituidos y método para usarlos | |
BR112015006571A2 (pt) | composição farmacêutica, processo para preparar uma composição farmacêutica, uso de uma composição farmacêutica, e, método para a profilaxia ou tratamento de asma, doença pulmonar obstrutiva crônica e distúrbios respiratórios relacionados | |
BR112018007161A2 (pt) | pirazolo[3,4-b]piridin-6-carboxamidas n-sulfoniladas e métodos de uso | |
UY29506A1 (es) | Nuevas formas cristalinas de bromuro de tiotropio | |
EA201791780A1 (ru) | Ингаляционный раствор тиотропия для небулайзерного распыления | |
CA2897464C (en) | Methods of treating autoimmune, respiratory and inflammatory disorders by inhalation of roflumilast n-oxide | |
UY35963A (es) | Determinadas (2s)-n-[(1s)-1-ciano-2-feniletil]-1,4-oxazepan-2-carboxamidas como inhibidores de dipeptidil peptidasa 1 | |
ECSP066543A (es) | Nuevo anhidrato cristalino con accion anticolinergica | |
BR112018007145A2 (pt) | ácidos pirazolo[3,4-b]piridin-6-carboxílicos substituídos e o seu uso | |
CL2014000122A1 (es) | Compuestos derivados de indazol, inhibidores de janus quinasa (jak); composicion farmaceutica que los comprende; y su uso para tratar rinitis alergica, congestion nasal, asma, bronquitis cronica, artritis, insuficiencia cardiaca, colitis ulcerativa, infeccion viral y bacteriana, cancer y alzheimer, entre otras enfermedades. | |
BR112014003225A2 (pt) | profármacos de treprostinil ligados a veículo | |
WO2006117300A3 (en) | Crystalline forms of tiotropium bromide | |
ECSP066545A (es) | Procedimiento para la preparación de sales de tiotropio, sales de tiotropio, así como formulaciones medicamentosas que las contienen | |
EA201190108A1 (ru) | Фармацевтическая композиция для ингаляции | |
SI2968312T1 (en) | Combination of Medicines | |
EA201590030A1 (ru) | Ингаляторы сухого порошка, содержащие носитель, отличный от лактозы, и третий компонент | |
EA201290374A1 (ru) | Аэрозольная композиция для copd | |
BR112014018767A8 (pt) | Compostos de pirroldicarboxamidas fundidas e composição farmacêutica que os compreende | |
PE20170073A1 (es) | Combinaciones de bromuro de tiotropio, formoterol y budesonida para el tratamiento de la copd | |
EA201590019A1 (ru) | Ингаляторы сухого порошка, содержащие носитель, отличный от лактозы | |
ECSP055821A (es) | Nueva formulacion pulverulenta que contiene tiotropio destinado a la inhalación | |
PT115583B (pt) | Processo contínuo para a preparação de medicamentos anticolinérgicos | |
BR112016002222A2 (pt) | partículas inaláveis compreendendo tiotrópio e indacaterol | |
UA115989C2 (uk) | Фармацевтична композиція для інгалятора сухого порошку, що містить антагоністи мускаринових рецепторів тривалої дії | |
EA029678B9 (ru) | Четвертичные соли пиперидиния |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
BB1A | Laying open of patent application |
Effective date: 20210531 |
|
FG3A | Patent granted, date of granting |
Effective date: 20220427 |